AFL atrial flutter AH arterial hypertension ANS autonomic nervous system APD action
potential duration ARREST-AF Aggressive Risk Factor Reduction Study for Atrial Fibrillation …

Efficacy and safety of cryoballoon ablation for atrial fibrillation: A systematic review of published
studies - ScienceDirect Skip to main contentSkip to article Elsevier logo Journals & Books …

前言心房颤动(房颤) 是临床上最常见的室上性心动过速. 据Framingham 研究提示[1],
人群患病率为0.5% 左右, 且随年龄增长其患病率增高; 60 岁以上的人群中, 其患病率可达6%; …

前言自2010 年中华医学会心电生理和起搏分会(China Society of Pacing and
Electrophysiology, CSPE) 制订并发表《 心房颤动: 目前的认识和治疗建议——2010》 以来 …

Background Since the release of the second-generation cryoballoon (CB2; Arctic Front
Advance TM, Medtronic Inc) and its design modifications with improved cooling …

Objectives: The purpose of this study was to investigate the efficacy safety of the novel
cryoballoon device (Arctic Front, Cryocath, Quebec, Canada). Background: Antral pulmonary …

Aim Cryoballoon ablation (Cryoballoon) has emerged as a new alternative for the treatment
of symptomatic drug-refractory atrial fibrillation (AF). Whether the results of Cryoballoon are …

Aims Cryothermal energy (CTE) ablation via a balloon catheter (Arctic Front, Cryocath™)
represents a novel technology for pulmonary vein isolation (PVI). However, balloon-based …

Improved Efficacy of SecondGeneration Cryoballoon Background The secondgeneration
cryoballoon (CB2) has recently been introduced featuring improved surface cooling …

Efficacy of the Novel Cryoballoon Introduction The cryoballoon technology has the potential
to isolate a pulmonary vein (PV) with a single energy application. However, using the first …